The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant investment in emerging technology

26 Feb 2021 10:47

RNS Number : 5081Q
Sabien Technology Group PLC
26 February 2021
 

26 February 2021

Sabien Technology Group plc

("Sabien" or the "Company")

 

Significant investment in emerging technology

 

The Board of Sabien, is pleased to announce that it has invested £100,000 in Aeristech Limited ("Aeristech"), a leading UK-based manufacturer of power-dense compressors used within hydrogen fuel cells. The investment is being funded by Sabien's existing resources as part of a £5.1 million pre-IPO funding round completed by Aeristech.

Sabien has subscribed for 41,667 shares in Aeristech, equivalent to 0.3% of the issued share capital of Aeristech as enlarged by the funding round, at an issue price of £2.40 per share. In addition, Aeristech has issued Sabien with 10,417 warrants with a two-year term, each warrant carrying the right to subscribe for one share in Aeristech at the issue price of £2.40.

Aeristech is a designer, producer, and supplier of efficient, power-dense compressors, which are used to maximise the power output and efficiency of hydrogen fuel cells. The company's unique, patented motor and controller technology provides significant performance benefits, including:

 

· Reducing high power switching events;

· Enabling high-speed and high-power motors;

· Reducing heat loss; and

· Mitigating costs by removing the need for high-cost specialist components.

 

Currently, Aeristech is partnered with three leading automotive tier-one suppliers. Several of these fuel cell customers are exhibiting strong performance as the hydrogen fuel cell market continues to grow, notably within the energy and transport sectors. The funding round will enable Aeristech to draw on £9.6m of UK Government grant funding for three hydrogen power development programs: two in the aerospace sector and one in automotive production.

 

Commenting on the investment, Richard Parris, Chairman of Sabien, stated: "Sabien believes that environmental and shareholder benefits are not mutually exclusive. We are focused on building a portfolio of solutions which reduce CO2 production at the point of consumption. Aeristech fits this template completely. Its work within hydrogen fuel cell optimisation is class-leading and the resulting technology will be, I am sure, capable of significant growth. The Sabien Board is pleased to be able to collaborate with Aeristech on this journey, providing the funds to assist in building a better future."

 

For Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman 

 

 +44 20 7993 3700 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Asha Chotai 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

+44 207 469 0930

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman. A copy of this announcement will be available from the Company's website at www.sabien-tech.co.uk 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKABQKBKDPBB
Date   Source Headline
7th Jul 20217:00 amRNSTrading Update
25th Jun 202111:15 amRNSOperational Update
18th Jun 20217:00 amRNSAppointment of Chief Scientific Officer
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20215:00 pmRNSTotal Voting Rights
29th Mar 20213:45 pmRNSResult of AGM
25th Mar 20217:00 amRNSHalf-year Report
19th Mar 20218:45 amRNSHolding(s) in Company
11th Mar 20214:57 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSCorporate Update - US Subsidiary Established
8th Mar 202110:59 amRNSCorporate Update - Contract win
5th Mar 202112:32 pmRNSNotice of Annual General Meeting
5th Mar 20217:00 amRNSAppointment of Chief Financial Officer
3rd Mar 20214:33 pmRNSHolding(s) in Company
3rd Mar 202110:00 amRNSHolding(s) in Company
1st Mar 20215:06 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSHolding(s) in Company
26th Feb 20215:00 pmRNSTotal Voting Rights
26th Feb 202110:47 amRNSSignificant investment in emerging technology
24th Feb 20212:10 pmRNSHolding(s) in Company
24th Feb 202112:16 pmRNSHolding(s) in Company
23rd Feb 20213:45 pmRNSChange of Registered Office
22nd Feb 202110:35 amRNSResult of General Meeting and Total Voting Rights
12th Feb 20217:00 amRNSHolding(s) in Company
11th Feb 202111:03 amRNSHolding(s) in Company
10th Feb 202111:38 amRNSHolding(s) in Company
3rd Feb 20214:11 pmRNSPlacing and Notice of General Meeting
1st Feb 20217:00 amRNSAppointment of Non-Executive Director
28th Jan 20214:32 pmRNSHolding(s) in Company
28th Jan 20218:14 amRNSHolding(s) in Company
27th Jan 20211:28 pmRNSChange of Substantial Shareholding
27th Jan 20211:26 pmRNSHolding(s) in Company
25th Jan 20217:00 amRNSBoard Changes
20th Jan 20217:30 amRNSRestoration - Sabien Technology Group PLC
20th Jan 20217:00 amRNSWithdrawal from acquisition and other matters
12th Jan 20215:38 pmRNSFrequently asked questions regarding the GM
5th Jan 20217:00 amRNSPosting of Circular and Notice of General Meeting
21st Dec 20205:23 pmRNSHolding(s) in Company
21st Dec 20205:20 pmRNSHolding(s) in Company
2nd Dec 20205:14 pmRNSPosting of Annual Report and Accounts
19th Nov 20207:00 amRNSFinal Results & Update on Proposed Acquisition
5th Nov 20207:00 amRNSChange of Registered Office
2nd Nov 20207:00 amRNSUpdate on Acquisition
14th Sep 20203:30 pmRNSCorporate Update - Contract win
27th Jul 20207:00 amRNSChange of Adviser
27th Jul 20207:00 amRNSUpdate re. Suspension
6th Jul 20207:00 amRNSTrading Update
29th May 202011:15 amRNSManagement Change, Furlough Update
31st Mar 20207:00 amRNSSabien furloughs staff in response to C19 lockdown

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.